Another warning this time from history Writing in the British Medical Journal in 1998, Abi Berger, a general practitioner, noted: "It must surely be every drug company's dream: to have a product so sexy that the need for marketing and public relations has been obviated by a tidal wave of media hype." It's as if the hype around GLP-1 agonists is a case of "history repeating"
Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model
This article explores the current science, clinical implications, and how to have informed, practical conversations with patients without overpromising results
Don't confuse these with the larger mixing syringe
This is intended to serve as a foundation. However, he says we need prospective studies, including large ones and those with control subjects
Because these products are being distributed illegally, they are not subject to the same regulations as normal medicines, explains Dr Wedgeworth